bluuebunny/crossref_metadata_2025_split huggingface dataset:
A Wide-Band High-Gain Doherty Power Amplifier With Class-AB HEMT Amplifiers
Authors: Jahanian Pouya , Kangarshahi Azadeh Norouzi 
Published: December 2021

Abstract
In this paper, an attempt has been made to design a Doherty power amplifier (DPA) with high-gain and wide-band. For this purpose, two peak amplifiers are used to improve the performance of the main amplifier. Main and auxiliary amplifiers with the same structure to the class-AB type and by using micro-strip lines in place of input/output and load matching networks, transmission lines and inductors of drain and gate, that minimize the losses in the DPA. The current DPA is implemented with GaN_HEMT_CLF1G0530_100v transistor and Rogers4003 substrate, which for 1GHz frequency in 0.5-1.5GHz bandwidth will be able to be at P-1dB point (this point, input power as 30dBm and output power as 47.98dBm) increase Drain efficiency and Power added efficiency (PAE) to 81.95% and 80.73%, respectively. The DPA helps to expand the back-off region and extend the linearity region, so the Peak to average power ratio (PAPR) will be 5.21dB and the Adjacent channel power ratio (ACPR) as 58.7dBc. A gain of 17.06-17.92dB was also obtained, which is significant compared to the results of similar samples.
Effect of Linc-00475 Regulation of p53 on Glycolysis and Survival in Gastric Cancer
Authors: Zhang Chao , Zhao Shutao , Wang Xudong 
Published: December 2021

Abstract
Background: Abnormal glucose metabolism leading to tumor proliferation and metastasis is an important area of interest in cancer treatment. The purpose of this study was to investigate the effects of clinical expression of glucose metabolism-related genes Linc-00475 and p53 on glycolysis and survival.Methods: A key differential gene Linc-00475 was screened using a metabolic database, and its downstream gene, p53, was predicted. A total of 107 gastric cancer tissue samples from patients diagnosed at our center between 2011 and 2013 were selected. The expression levels of Linc-00475 and p53 were detected via in situ hybridization or immunohistochemistry. Chi-square test was used to analyze the relationship between Linc-00475 and p53 expression and clinicopathological factors. Kaplan-Meier method and log rank test were used to analyze patients’ overall survival. To determine the effect of Linc-00475 on glycolysis, qRT-PCR and western blot were utilized to evaluate the regulatory relationship between Linc-00475 and p53.Results: High expression of Linc-00475 (P < 0.001) and low expression of p53 (P < 0.01) were associated with poor prognosis. There was a negative correlation between the expression of Linc-00475 and p53 in gastric cancer (Pearson's coefficient test, r = -0.405; P < 0.001). The co-expression of high-level Linc-00475 and low-level p53 can thus be used as an independent prognostic factor (P = 0.001). Linc-00475 was also shown to regulate aerobic glycolysis. Western blot and qRT-PCR demonstrated that Linc-00475 regulates the expression of p53.Conclusion: The co-expression of Linc-00475 and p53 can be used as a reference index for evaluating the prognosis of gastric cancer. Linc-00475 regulates p53, thereby affecting glycolysis.
The Biases in Flavonoids and Anthocyanin Biosynthesis of a Red Flesh Table Grape Revealed by Metabolome and Transcriptome Co-analysis
Authors: lu renxiang , Song Miaoyu , Wang Zhe , Zhai Yanlei , Hu Chaoyang , Perl Avihai , Ma Huiqin 
Published: December 2021

Abstract
Red flesh is a welcomed fruit trait, yet the regulation of red flesh formation in grape is not well understood. ‘Mio Red’ is a seedless table grape variety with light red flesh and blue-purple skin, the flesh color developed in the late stage of berry ripening, remarkably later than the skin coloring at veraison. The flesh and skin flavonoids metabolome and the transcriptome were analyzed. A total of 173 flavonoids including 17 anthocyanins were identified, 68 were found significantly different (Fold change ≥ 2 or ≤ 0. 5, VIP ≥ 1). Quercetin 3-O-glucoside, epicatechin-epiafzelechin, apigenin 6,8-C-diglucoside and hesperetin 5-O-glucoside were of higher content in the flesh, while the rest flavonoids were of higher content in the skin. The main anthocyanin in the flesh was pelargonidin derivatives in contrast to peonidin derivatives in the skin. Transcriptome comparison recruited 3970 differentially expressed genes (DEGs, log2Fold change > = 1, FDR < 0.05, FPKM ≥ 1), among them 57 were structural genes of flavonoid metabolism pathway. Two anthocyanin synthase (ANS) DEGs were annotated, ANS1 (Vitvi11g00565) and ANS2 (Vitvi02g00435) led the expression in the flesh and skin respectively. In the flesh, anthocyanin biosynthesis structural gene UFGT, positive regulators MYBA1/2/3, and anthocyanin transporters GST14 and MATE5 were of significantly lower expression, while negative regulators MYBC2-L1 and MYB3 were of higher transcription. The results of this study provide new information in the coloring mechanism of red flesh grape and assisting breeding of future table grapes having higher content of phytonutrient providing the health benefit as red wines.
Outcomes and indications of the single approach to double-channel core decompression and bone grafting with structural bone support for osteonecrosis of the femoral head
Authors: Yue Ju’an , Guo Xiaozhong , Wang Randong , Li Bing , Sun Qiang , Liu Wangyan , Chen Jiao 
Published: December 2021

Abstract
BackgroundTo report the outcomes of the single approach to double-channel core decompression and bone grafting with structural bone support (SDBS) for osteonecrosis of the femoral head (ONFH) and define the indications.MethodsOne-hundred-and-thirty-nine hips in 96 patients (79 males, 17 females; mean age 37.53±10.31 years, range 14–58 years; mean body mass index 25.15±3.63 kg/m2) were retrospectively analysed. The Harris hip score (HHS) was used to assess hip function, and radiographs were used to assess the depth of femoral head collapse. Treatment failure was defined as the performance of total hip arthroplasty (THA). The variables assessed as potential risk factors for surgical failure were: aetiology, Japanese Osteonecrosis Investigation Committee (JIC) type, age, and Association Research Circulation Osseous (ARCO) stage. Complications were recorded.ResultsThe HHS increased from 79.00±13.61 preoperatively to 82.01±17.29 at final follow-up (P=0.041). The average HHS improvement was 3.00±21.86. The combined excellent and good rate at final follow-up (65.6%) was significantly higher than that before surgery (34.5%) (P=0.000). On radiographic evaluation, 103 (74.1%) hips remained stable, while 36 (25.9%) had femoral head collapse or aggravation of ONFH. THA was performed in 18 hips. Thus, the overall femoral head survival rate was 87.05% (121/139). The success rate was adversely affected by JIC type, but not by aetiology, age, or ARCO stage. The only complication was a subtrochanteric fracture in one patient.ConclusionThe SDBS effectively delays or even terminates the progression of ONFH, especially type B and C1. The SDBS is a good option for early-stage ONFH.
Safety, Tolerability and Immunogenicity of Oxford-AstraZeneca ChAdOx1 Vaccine Among Polish School-Teachers
Authors: Ganczak Maria , Korzeń Marcin , Sobieraj Ewa , Goławski Jakub , Pasek Oskar , Biesiada Daniel 
Published: December 2021

Abstract
Background

Polish teachers, as the priority group, were offered the ChAdOx1-S vaccine since February 2021. The objective was to investigate safety, tolerability and immunogenicity of this vaccine following two vaccine doses.
Methods

Teachers were invited for serological testing ≥8 weeks after second vaccination. Quantitative post-vaccination anti-spike antibody responses were measured using the Abbott SARS-CoV-2 IgG II Quant assay (detection threshold: ≥7.1 BAU/ml). Multivariable logistic regression methods were used to identify predictors of immunogenicity.
Results

Of 192 teachers, mean age 50.5±8.3 years, 83.9% were females. Median (range) dosing interval was 50 (14-95) days; median interval between the second dose and immunogenicity test was 69 days (range: 57–111). More than a half of teachers (58.3%) reported they would change the product for another (mostly mRNA) vaccine if there was such an opportunity. Adverse reactions after receiving the vaccine (either the first or the second dose) were reported by 79.2% teachers, more frequently after the first dose (84.9%), and were similar in nature to those previously reported: feeling feverish (44.8%), headache (41.7%), malaise, chills (both: 38.0%), injection-site tenderness (37.5%) and pain (32.3%). Less males than females (54.8% vs 80.1%) and older (aged ≥50 years) than younger teachers (65.7% vs 90.4%) reported side effects (p<0.002; p<0.0001, respectively). By ≥8 weeks after the boost dose, all teachers had neutralizing antibody responses. The median (range) anti-spike IgG reading was 525.0 BAU/mL (20.6-5680.0 BAU/mL); 1008.02 (115.3–5680.0) BAU/mL in teachers with evidence of prior infection and 381.42 BAU/mL (20.6–3108.8) in those without (p=0.001). Previous infection with SARS-CoV-2 and longer dose interval were both positive predictors of higher immunologic response (p<0.0001; p=0.01, respectively), with no evidence of differences by age, gender, BMI, smoking or comorbidities.
Conclusions

The results demonstrated good safety, tolerability and immunogenicity of the ChAdOx1-S vaccine. Immunization led to detectable anti-spike antibodies in all teachers. Our study justifies the longer dose interval as an important factor to enhance higher antibody response. Findings suggest that in immunocompetent vaccine recipients with an evidence of previous infection a delay regarding the second dose could be considered when careful management in the use of vaccine resources is needed.
A Randomized, Double-blind, Placebo-controlled Trial of DL-3-n-butylphthalide in Amyotrophic Lateral Sclerosis Patients
Authors: Liu Mingsheng , Yao Xiaoli , Huang Xusheng , Shang Huifang , Fan Dongsheng , He Jia , Cui Liying 
Published: December 2021

Abstract
Background: To determine the efficacy and safety of DL-3-n-butylphthalide (NBP) for the treatment of amyotrophic lateral sclerosis (ALS).Methods: A randomized, double-blind, placebo-controlled trial was performed at 19 ALS clinical centers of the Chinese ALS Association. Patients with definite or probable ALS were randomly treated with NBP or placebo for 12 months. The Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) score was the primary endpoint and was evaluated every 3 months. Secondary endpoints included survival and tracheotomy incidence, total Medical Research Council (MRC) score, percentage of predicted forced vital capacity (FVC), and clinical global impression scale score assessed using the visual analog scale. Results: Between November 23, 2015 and November 22, 2017, 312 ALS patients were enrolled and randomly allocated to either the NBP group (156 patients) or placebo group (156 patients). Ninety-three patients in the NBP group and 92 patients in the placebo group were included in the primary end point analysis. There was no significant difference in the ALSFRS-R score, total MRC score, or clinical global impression between the two groups after treatment. The NBP group exhibited a mild trend of less decrease in the percentage of predicted FVC between baseline and the 12-month visit than the placebo group (least-squares mean change from baseline ± standard error: -7.34±4.28, 95％CI(-15.24,0.56), p=0.0335). Adverse events were reported in 56.5% of patients in the placebo group and 68.8% of patients in the NBP group (χ2=2.99, P=0.0838). No serious adverse event related to treatment occurred.Conclusion: we found no evidence that NBP improved the ALSFRS-R score in patients with ALS. The results suggest a mild trend in the percentage of predicted FVC decreased slowly in the NBP treatment group than in the placebo group.Trial registration: A Multi-center, Randomized, Double Blinding, Placebo-Controlled Clinical Trial of Dl-3-Butylphthalide in the Treatment of Amyotrophic Lateral Sclerosis, ChiCTR-IPR-15007365, Registered 1 November 2015, http://www.chictr.org.cn/showproj.aspx?proj=12354
What is the Role of Vitamin D in the Severity and Control of Asthma in Children and Adolescents: a Protocol for a Systematic Review
Authors: Ladeira Joelia Maria Maria Costa Dias , Zacas Olívia , Toro Adyleia Aparecida Dalbo Contrera , Grotta Milena Baptistella , Ferreira Amanda Miranda , Stegun Patrícia Chaib Gomes 
Published: December 2021

Abstract
Background: Vitamin D plays an important role in the immune system and consequently in the inflammatory process of asthma. It acts directly on the regulation of Th1 and Th2 cells and regulatory T lymphocytes. Evidence shows that vitamin D can act on dendritic cells, raising inflammatory mediators and increasing the imbalance between Th1, Th2, and Th17. Understanding the link between vitamin D and inflammatory processes in the control and severity of asthma is important for the existence of specific therapies. Objective: We aim to synthesize the scientific evidence about the role of Vitamin D in the control and severity of asthma in pediatric patients by a systematic review. Methods: A systematic and comprehensive search will be performed using MEDLINE PubMed, BIREME, EBSCOhost, Scopus, Web of Science, EMBASE, Cochrane Library, and ProQuest. From the data obtained, all the articles found will be transferred to the Rayyan platform. Study selection will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist (PRISMA-2020). Additionally, if sufficient data are available, a meta-analysis will be conducted.Discussion: The ability of vitamin D to act in the immune system with a direct action on the inflammatory asthma cascade, allows for a better understanding of the disease. This will lead to better asthma management, and, consequently, to help in controlling the disease. The conduction of a systematic review will bring better knowledge about vitamin D and its role in the pathophysiology of asthma Systematic review registration:This protocol has been registered in the PROSPERO and the registration number is CRD42021221638.
Clinically Delivered Treatment for Glioma Patients on Hybrid Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) versus Cone Beam CT (CBCT)-Guided Linac
Authors: Wang Michael H. , Kim Anthony , Ruschin Mark , Tan Hendrick , Soliman Hany , Myrehaug Sten , Detsky Jay , Husain Zain , Atenafu Eshetu G. , Keller Brian , Sahgal Arjun , Tseng Chia-Lin 
Published: December 2021

Abstract
Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) radiotherapy is an innovative technology that requires special consideration for secondary electron interactions within the magnetic field, which can alter dose deposition at air-tissue interfaces. Thirty-seven consecutive glioma patients had treatment planning completed and approved prior to radiotherapy initiation using commercial treatment planning systems (TPS): a Monte Carlo-based or convolution-based TPS for MR-Linac or Cone Beam CT (CBCT)-guided Linac, respectively. In vivo skin dose was measured using an Optically Stimulated Luminescent Dosimeter (OSLD) and correlated with TPS skin dose. We found that Monte Carlo-based MR-Linac plans and convolution-based CBCT-Linac plans had similar dosimetric parameters for target volumes and organs-at-risk. However, MR-Linac plans had 1.52 Gy higher mean dose to air cavities (p<0.0001) and 1.10 Gy higher mean dose to skin (p<0.0001). In vivo skin dose was 14.5% greater for MR-Linac (p=0.0027), and were more accurately predicted by Monte Carlo-based calculation (ρ=0.95, p<0.0001) vs. convolution-based (ρ=0.80, p=0.0096). This is the first prospective dosimetric comparison of glioma patients clinically treated on both MR-Linac and CBCT-guided Linac. Skin doses were significantly greater with MR-Linac and correlated with in vivo measurements. Future MR-Linac planning processes are being designed to account for skin dosimetry and treatment delivery.
Regulatory T Cell as Predictor of Intramyocardial Hemorrhage in STEMI Patients After Primary PCI
Authors: Zhang Yue , Gao Hui , Liu Lei , Li Shengyu , Hua Bing , Lan Dihui , He Yi , Li Jinshui , Li Weiping , Li Hongwei 
Published: December 2021

Abstract
Background: Intramyocardial hemorrhage (IMH) is a result of ischemia-reperfusion injury in ST-segment elevation myocardial infarction(STEMI) after primary percutaneous coronary intervention (PPCI). Despite patients with IMH show poorer prognoses, studies investigating predictors of IMH occurrence are scarce. This study firstly investigated the effectiveness of regulatory T cell (Treg), peak value of Creatine Kinase MB (pCKMB), high-sensitivity C-reactive protein (hsCRP), and left ventricular end-systolic diameter (LVESD) as predictors for IMH in STEMI patients received PPCI.Methods: A prospective observational cohort study was performed in STEMI patients with cardiac magnetic resonance examination 6.3±2.3 days after PPCI. Logistic regression analysis was used to screen the risk factors for IMH. The predictive ability of risk factors for IMH were determined by Receiver operating characteristic curves, net reclassification improvement (NRI), integrated discrimination improvement (IDI) and C-index.Results: Of the 182 patients, 80 patients (44.0%) developed IMH. On multivariable analysis, all 4 biomarkers were independent predictors of IMH [odds radio (OR) and 95% confidence interval (CI): 0.350(0.202-0.606) for Treg, 1.004(1.001-1.006) for pCKMB, 1.060(1.022-1.100) for hsCRP, and 3.329(1.346-8.236) for LVESD]. After propensity score matching, the biomarkers individually and together significantly predicted IMH with areas under the curve of 0.750 for Treg, 0.721 for pCKMB, 0.656 for hsCRP, 0.633 for LVESD, and 0.821 for the integrated 4-marker panel. The addition of integrated 4-marker panel to a baseline risk model had an incremental effect on the predictive value for IMH [NRI: 0.197 (0.039 to 0.356); IDI: 0.200 (0.142 to 0.259); C-index: 0.806 (0.744 to 0.869), all p < 0.05].Conclusions: Treg individually or in combination with pCKMB, hsCRP, and LVESD can effectively predict the existence of IMH in STEMI patients received PPCI.Name of the registry: ClinicalTrials. govTrial registration number: NCT03939338Date of registration: 6 May 2019URL of trial registry record: https://clinicaltrials.gov/ct2/show/NCT03939338?term=03939338&cntry=CN&draw=2&rank=1
Association Between the Blautia/Bacteroides Ratio and Altered Body Mass Index After Bariatric Surgery
Authors: Kim Yoonhong , Son Doo Heon , Lim Sanghyun , Kim Bu Kyung , Kim Ki Hyun , Seo Kyung Won , Jung Kyoungwon , Park Seun Ja , Kim Jae Hyun 
Published: December 2021

Abstract
Current evidence support that the gut microbiota plays a potential role in obesity. Bariatric surgery can reduce excess weight and decrease the risk of life-threatening weight-related health problems and may also influence gut microbiota. In this study, we aimed to investigate the changes in gut microbiota before and after bariatric surgery and evaluate the association of the gut microbial shift and altered body mass index (BMI) after bariatric surgery. Between January 2019 and July 2020, stools from 58 patients scheduled for bariatric surgery were collected. Six months after bariatric surgery, stools from 22 of these patients were re-collected, and the changes in gut microbiota before and after bariatric surgery were evaluated. In addition, the differences in gut microbiota between patients with severe obesity (BMI > 35, n=42) and healthy volunteers with normal BMI (18.8 – 22.8, n=41) were investigated. The gut microbiota of patients who underwent bariatric surgery showed increased α-diversity and differed β-diversity compared with those before surgery. Interestingly, Blautia was decreased and Bacteriodes was increased at the genus level after bariatric surgery. Further, the Blautia/Bacteroides ratio showed a positive correlation with BMI. These results were similar regardless of the surgery type (Roux-en-Y gastric bypass or sleeve gastrectomy). To validate these results, we compared the gut microbiota from severely obese patients with high BMI with those from healthy volunteers and demonstrated that the Blautia/Bacteroides ratio correlated positively with BMI. In the gut microbial analysis of patients who underwent bariatric surgery, we identified that the Blautia/Bacteroides ratio had changed after bariatric surgery and showed a positive correlation with BMI. Based on these results, we suggest that bariatric surgery could change the gut microbiota and specific microbiomes might have a potential role in obese patients.
Visual Interpretation of Brain Hypometabolisms Related to Neurological Long COVID: A French Multicentric Experience
Authors: Verger Antoine , Kas Aurélie , Dudouet Pierre , Goehringer François , Salmon Dominique , Guedj Eric 
Published: December 2021

Abstract
This multicenter study aims to provide a qualitative and consensual description of brain 18F-FDG PET images in patients with suspected neurological long COVID, regarding the previously reported pattern involving olfactory bulbs and other limbic/paralimbic regions, as well as the brainstem and cerebellum.Methods: From the beginning of August 2021 to the end of October 2021, brain 18F-FDG PET exams of patients referred for suspected neurological long COVID with positive reverse transcription polymerase chain reaction (RT-PCR) and/or serology for the SARS-CoV-2 infection were retrospectively reviewed in three French Nuclear Medicine departments. Experimented nuclear physicians from each department had to classify according to the same visual interpretation analysis brain 18F-FDG PET scans as being normal, mildly to moderate (incomplete or moderately hypometabolic), or severely affected within the previously reported long COVID hypometabolic pattern. Results: On the 143 brain 18F-FDG PET performed during this period 3 months, 53% of scans were visually interpreted as normal, 31% as mildly to moderate and 16% as severely affected according to the COVID hypometabolic pattern. Importantly, this specific hypometabolic pattern is reported as identical in the three Nuclear Medicine departments. Typical illustrative examples are provided to help nuclear physicians in the interpretation of long COVID pattern.Conclusion: The proposed PET metabolic pattern is easily identified at visual interpretation in clinical routine in part of patients with suspicion of neurological long COVID, requiring special consideration for fronto-basal paramedian regions, the brainstem and cerebellum.
Case series: Criss-cross Heart
Authors: Patrakunwiwat Panthip , Makarapong Pirapat , Layangkool Thanarat 
Published: December 2021

Abstract
Criss-cross heart (CCH) is a rare cardiac malformation which is characterized by crossing of the inflow streams of the two ventricles due to rotation of ventricular axis. The anomalies can be identified both atrioventricular concordance and discordance. The etiology of CCH is remaining unknown. Prominent symptom is cyanosis. The primary investigation is transthoracic echocardiography to identify this abnormality. Many patients need further investigation to review anatomy. Total correction is the aim for treatment but it is difficult for this complex anatomy. There were 5 patients who visited cardiology clinic at Queen Sirikit National Institute of Child Health (QSNICH) from 2002 to 2017. The objective is to review the treatment options that we performed in CCH. Most common associated anomalies were double outlet right ventricle and pulmonary stenosis. One patient died before surgical intervention; others were performed palliative surgery.